First published by ALM / Law.com in The Intellectual Property Strategist. I. INTRODUCTION This article briefly analyzes recent Patent Trial and Appeal Board (“PTAB”) decisions on medical technology incorporating artificial intelligence (AI). Each decision involves reversal of a prior art rejection and contrasts with the other decisions on subject matter eligibility. The innovations at issue relate... Continue Reading

View Entire Post